Description: Rhythm Biosciences Ltd is an Australia-based company, which develops a medical diagnostic technology for colorectal cancer, ColoStat. ColoStat technology is a blood test for screening colorectal cancer. The test is an immunoassay biochemical test that detects the presence of multiple protein biomarkers for colorectal cancer. It detects the colorectal cancer at all stages including the early ones.
Home Page: www.rhythmbio.com
RHY Technical Analysis
RBC Funds Trust
,
Phone:
61 3 8256 2880
Officers
| Name | Title |
|---|---|
| Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD | Exec. Chairman |
| Mr. Glenn Gilbert | MD, CEO & Director |
| Dr. Trevor John Lockett Ph.D. | Technical Director, Chair of the Clinical Advisory Board & Exec. Director |
| Mr. Paul Smith | Chief Financial Officer & Joint Company Sec. |
| Ms. Andrea Steele LLB B Com LLM | Gen. Counsel & Company Sec. |
| Ms. Elena Deak | Chief Commercial Officer |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 32.698 |
| Price-to-Sales TTM: | 87.6758 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |